Sage Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023
January 03 2023 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical
company leading the way to create a world with better brain health,
announced today that the Company will present at the 41st Annual
J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at
10:30 a.m. PT in San Francisco, CA.
A live webcast of the presentation can be accessed on the
Investor page of Sage’s website at investor.sagerx.com. A replay of
the webcast will be available following the completion of the event
and will be archived for up to 30 days.
About Sage Therapeutics Sage Therapeutics is a
biopharmaceutical company fearlessly leading the way to create a
world with better brain health. Our mission is to pioneer solutions
to deliver life-changing brain health medicines, so every person
can thrive. For more information, please visit. www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230103005159/en/
Investors Helen Rubinstein 315-382-3979
helen.rubinstein@sagerx.com
Media Matthew Henson 917-930-7147
matthew.henson@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2023 to Sep 2024